Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne, GM Duchesne… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): A randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne, GM Duchesne… - 2020 - ro.ecu.edu.au
Abstract© 2020 Elsevier Ltd Background: Adjuvant radiotherapy has been shown to halve
the risk of biochemical progression for patients with high-risk disease after radical …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne… - The Lancet …, 2020 - researchers.mq.edu.au
Background: Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

[引用][C] Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne, GM Duchesne… - The Lancet …, 2020 - cir.nii.ac.jp
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG
08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial | CiNii Research …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne, GM Duchesne… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne, GM Duchesne… - The Lancet …, 2020 - europepmc.org
Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne… - The Lancet …, 2020 - research.monash.edu
Background: Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne, GM Duchesne… - The Lancet …, 2020 - Elsevier
Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne, GM Duchesne… - 2020 - wslhd.intersearch.com.au
BACKGROUND: Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …